Works matching IS 13524585 AND DT 2020 AND VI 26

Results: 293
    1
    2
    3

    Abstracts.

    Published in:
    Multiple Sclerosis Journal, 2020, v. 26, p. 1
    Publication type:
    Article
    4
    5

    Table of Contents.

    Published in:
    Multiple Sclerosis Journal, 2020, v. 26, p. 1, doi. 10.1177/1352458520969073
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13

    Smelling the danger.

    Published in:
    Multiple Sclerosis Journal, 2020, v. 26, n. 14, p. 1960, doi. 10.1177/1352458520912380
    By:
    • Yong, Kok Pin;
    • Kim, Ho Jin
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20

    Safety, feasibility, acceptability and effects of a behaviour-change intervention to change physical activity behaviour among people with multiple sclerosis: Results from the iStep-MS randomised controlled trial.

    Published in:
    Multiple Sclerosis Journal, 2020, v. 26, n. 14, p. 1907, doi. 10.1177/1352458519886231
    By:
    • Ryan, Jennifer M;
    • Fortune, Jennifer;
    • Stennett, Andrea;
    • Kilbride, Cherry;
    • Lavelle, Grace;
    • Hendrie, Wendy;
    • DeSouza, Lorraine;
    • Abdul, Mohammed;
    • Brewin, Debbie;
    • David, Lee;
    • Anokye, Nana;
    • Victor, Christina;
    • Norris, Meriel
    Publication type:
    Article
    21
    22
    23
    24

    Cognitive processing speed in pediatric-onset multiple sclerosis: Baseline characteristics of impairment and prediction of decline.

    Published in:
    Multiple Sclerosis Journal, 2020, v. 26, n. 14, p. 1938, doi. 10.1177/1352458519891984
    By:
    • Wallach, Asya I;
    • Waltz, Michael;
    • Casper, T Charles;
    • Aaen, Gregory;
    • Belman, Anita;
    • Benson, Leslie;
    • Chitnis, Tanuja;
    • Gorman, Mark;
    • Graves, Jennifer;
    • Harris, Yolanda;
    • Lotze, Timothy E;
    • Mar, Soe;
    • Moodley, Manikum;
    • Ness, Jayne M;
    • Rensel, Mary;
    • Rodriguez, Moses;
    • Rose, John W;
    • Schreiner, Teri;
    • Tillema, Jan-Mendelt;
    • Waubant, Emmanuelle
    Publication type:
    Article
    25
    26

    Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies.

    Published in:
    Multiple Sclerosis Journal, 2020, v. 26, n. 14, p. 1866, doi. 10.1177/1352458519888610
    By:
    • Comi, Giancarlo;
    • Alroughani, Raed;
    • Boster, Aaron L;
    • Bass, Ann D;
    • Berkovich, Regina;
    • Fernández, Óscar;
    • Kim, Ho Jin;
    • Limmroth, Volker;
    • Lycke, Jan;
    • Macdonell, Richard AL;
    • Sharrack, Basil;
    • Singer, Barry A;
    • Vermersch, Patrick;
    • Wiendl, Heinz;
    • Ziemssen, Tjalf;
    • Jacobs, Alan;
    • Daizadeh, Nadia;
    • Rodriguez, Claudio E;
    • Traboulsee, Anthony;
    • Baker, Darren P.
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Diroximel fumarate (DRF) in patients with relapsing–remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study.

    Published in:
    Multiple Sclerosis Journal, 2020, v. 26, n. 13, p. 1729, doi. 10.1177/1352458519881761
    By:
    • Naismith, Robert T;
    • Wolinsky, Jerry S;
    • Wundes, Annette;
    • LaGanke, Christopher;
    • Arnold, Douglas L;
    • Obradovic, Dragana;
    • Freedman, Mark S;
    • Gudesblatt, Mark;
    • Ziemssen, Tjalf;
    • Kandinov, Boris;
    • Bidollari, Ilda;
    • Lopez-Bresnahan, Maria;
    • Nangia, Narinder;
    • Rezendes, David;
    • Yang, Lili;
    • Chen, Hailu;
    • Liu, Shifang;
    • Hanna, Jerome;
    • Miller, Catherine;
    • Leigh-Pemberton, Richard
    Publication type:
    Article
    36
    37

    Efficacy of alemtuzumab over 6 years in relapsing–remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies.

    Published in:
    Multiple Sclerosis Journal, 2020, v. 26, n. 13, p. 1719, doi. 10.1177/1352458519881759
    By:
    • Van Wijmeersch, Bart;
    • Singer, Barry A;
    • Boster, Aaron;
    • Broadley, Simon;
    • Fernández, Óscar;
    • Freedman, Mark S;
    • Izquierdo, Guillermo;
    • Lycke, Jan;
    • Pozzilli, Carlo;
    • Sharrack, Basil;
    • Steingo, Brian;
    • Wiendl, Heinz;
    • Wray, Sibyl;
    • Ziemssen, Tjalf;
    • Chung, Luke;
    • Margolin, David H;
    • Thangavelu, Karthinathan;
    • Vermersch, Patrick
    Publication type:
    Article
    38

    Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study.

    Published in:
    Multiple Sclerosis Journal, 2020, v. 26, n. 13, p. 1670, doi. 10.1177/1352458519881428
    By:
    • Jakimovski, Dejan;
    • Zivadinov, Robert;
    • Ramanthan, Murali;
    • Hagemeier, Jesper;
    • Weinstock-Guttman, Bianca;
    • Tomic, Davorka;
    • Kropshofer, Harald;
    • Fuchs, Tom A;
    • Barro, Christian;
    • Leppert, David;
    • Yaldizli, Özgür;
    • Kuhle, Jens;
    • Benedict, Ralph HB
    Publication type:
    Article
    39

    Wilhelm Uhthoff and Uhthoff's phenomenon.

    Published in:
    Multiple Sclerosis Journal, 2020, v. 26, n. 13, p. 1790, doi. 10.1177/1352458519881950
    By:
    • Jain, Aarushi;
    • Rosso, Mattia;
    • Santoro, Jonathan D
    Publication type:
    Article
    40
    41
    42
    43

    Serum FAM19A5 in neuromyelitis optica spectrum disorders: Can it be a new biomarker representing clinical status?

    Published in:
    Multiple Sclerosis Journal, 2020, v. 26, n. 13, p. 1700, doi. 10.1177/1352458519885489
    By:
    • Lee, Hye Lim;
    • Seok, Hung Youl;
    • Ryu, Han-Wook;
    • Cho, Eun Bee;
    • Kim, Bong Chul;
    • Kim, Byoung Joon;
    • Min, Ju-Hong;
    • Seok, Jin Myoung;
    • Shin, Ha Young;
    • Kang, Sa-Yoon;
    • Kwon, Oh-Hyun;
    • Lee, Sang-Soo;
    • Oh, Jeeyoung;
    • Sohn, Eun-Hee;
    • Huh, So-Young;
    • Cho, Joong-Yang;
    • Seong, Jae Young;
    • Kim, Byung-Jo
    Publication type:
    Article
    44
    45
    46
    47

    Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype.

    Published in:
    Multiple Sclerosis Journal, 2020, v. 26, n. 13, p. 1765, doi. 10.1177/1352458519881994
    By:
    • Zhou, Yuan;
    • Claflin, Suzi B;
    • Stankovich, Jim;
    • van der Mei, Ingrid;
    • Simpson Jr, Steve;
    • Roxburgh, Richard H;
    • Kalincik, Tomas;
    • Blizzard, Leigh;
    • Lugaresi, Alessandra;
    • Alroughani, Raed;
    • Sajedi, Seyed Aidin;
    • Butzkueven, Helmut;
    • Pucci, Eugenio;
    • Spitaleri, Daniele LA;
    • Granella, Franco;
    • Cristiano, Edgardo;
    • Yamout, Bassem;
    • Hughes, Stella;
    • Gouider, Riadh;
    • Sánchez Menoyo, José Luis
    Publication type:
    Article
    48
    49
    50

    The long-term outcomes of CIS patients in the Barcelona inception cohort: Looking back to recognize aggressive MS.

    Published in:
    Multiple Sclerosis Journal, 2020, v. 26, n. 13, p. 1658, doi. 10.1177/1352458519877810
    By:
    • Tintore, Mar;
    • Arrambide, Georgina;
    • Otero-Romero, Susana;
    • Carbonell-Mirabent, Pere;
    • Río, Jordi;
    • Tur, Carmen;
    • Comabella, Manuel;
    • Nos, Carlos;
    • Arévalo, María Jesús;
    • Anglada, Elisenda;
    • Menendez, Rebeca;
    • Midaglia, Luciana;
    • Galán, Ingrid;
    • Vidal-Jordana, Angela;
    • Castilló, Joaquin;
    • Mulero, Patricia;
    • Zabalza, Ana;
    • Rodríguez-Acevedo, Breogan;
    • Rodriguez, Marta;
    • Espejo, Carmen
    Publication type:
    Article